Market
In Belgium, vitamin B2 (riboflavin) is primarily an imported bulk ingredient used in dietary supplement formulation and in vitamin fortification of foods under EU rules. Belgium applies a national pre-market notification procedure for food supplements (FOODSUP) and additional national requirements set out in Royal Decrees, with market controls performed by the Federal Agency for the Safety of the Food Chain (FASFC). Demand is driven by domestic consumption and by Belgian/EU distribution activities for finished supplements and fortified foods. Procurement and compliance priorities focus on ingredient purity specifications, claims/label compliance, and dossier-ready traceability documentation rather than seasonality.
Market RoleImport-dependent ingredient and supplement/fortification manufacturing market (EU single market)
Domestic RoleIngredient input for domestic supplement and fortified-food production, plus domestic retail consumption of finished supplements
Risks
Regulatory Compliance HighBelgium requires a pre-market notification procedure for food supplements and applies additional national Royal Decrees (including composition limits and labelling/advertising requirements); non-compliance can block lawful placing-on-the-market and trigger withdrawal/enforcement actions.Pre-check the finished supplement formula against Directive 2002/46/EC and relevant Belgian Royal Decrees; submit the FOODSUP notification dossier before marketing and retain the FPS receipt/letter and full technical file.
Claims And Labelling HighUse of non-authorised or non-compliant nutrition/health claims on riboflavin-containing supplements can lead to enforcement action and forced relabelling/withdrawal in Belgium under the EU nutrition and health claims framework.Use only authorised claims and conditions of use from the EU Register; run label and claim review as part of the Belgium notification and QA release checklist.
Food Safety MediumSpecification failures (e.g., potency shortfall, impurity exceedances, or microbiological non-conformance) can lead to batch rejection by Belgian buyers and increased scrutiny during market controls.Contractually lock specifications and test methods; require CoA per batch and perform incoming QC verification on a risk-based schedule.
Worker Safety MediumRiboflavin is a known photosensitiser and powder handling can create inhalable dust exposure risks for workers in blending and packaging operations.Implement closed transfer where feasible, local exhaust ventilation, dust monitoring, and PPE controls; include photosensitiser handling guidance in SOPs and SDS training.
Supply Concentration MediumGlobal riboflavin supply is concentrated in large-scale industrial production (often fermentation-based), increasing exposure to supplier outages, regulatory disruptions, or quality events that can interrupt Belgian manufacturing schedules.Qualify at least two approved suppliers and maintain safety stock sized to lead times; monitor supplier change controls and regulatory updates.
Labor & Social- Worker safety and hygiene controls for fine powders (dust management and PPE) are relevant during handling and blending operations in Belgium.
Standards- FSSC 22000
- ISO 22000
- GMP (food supplements) / HACCP-based food safety systems
FAQ
Do riboflavin-containing food supplements need to be notified before being sold in Belgium?Yes. Belgium applies a national notification procedure for food supplements (in addition to EU rules), and dossiers are handled through the FPS Public Health process (FOODSUP).
Which EU rules are the main baseline for vitamin B2 (riboflavin) used in food supplements and fortified foods in Belgium?For food supplements, the EU baseline is Directive 2002/46/EC (lists permitted vitamins/minerals and permitted sources). For adding vitamins/minerals to ordinary foods (fortification), the baseline is Regulation (EC) No 1925/2006.
What is a common compliance pitfall when marketing riboflavin supplements in Belgium?Using non-compliant nutrition or health claims. In the EU (including Belgium), nutrition and health claims must follow Regulation (EC) No 1924/2006 and the conditions of use shown in the EU Register.